PedCrin, C4C, INCiPiT and RECLIP: the role of TEDDY in the current European scenario of the paediatric Networks

PedCrin, C4C, INCiPiT and RECLIP: the role of TEDDY in the current European scenario of the paediatric Networks

The General Assembly of TEDDY, held in Rome on 14th January 2018, has provided the occasion to meet the representatives of the current European Paediatric Networks, in which TEDDY is involved, thus giving the possibility to discuss the recent strategies of cooperation in paediatric research. The presence and the cooperation of coordinated and specialized Networks, in fact, allows to join the synergies of researchers and professionals in order to invest time, energy and efforts to connect and share knowledge, thus building bridges across the scientific community. This strategy of cooperation represents a keystone in the context of the paediatric research, where a limited specific support by the institutions and existing research infrastructures is evident. Over the last years, some initiatives have arisen to cover this gap and TEDDY was avant-garde in this sense, followed by other Networks such as the Paediatric Clinical Research Infrastructure Network (PedCRIN), the Spanish Pediatric Clinical Trials Network (RECLIP) and Conect4Children (C4C), arisen with the common aim to promote the development of paediatric research and drugs tailored for children.

RECLIP and INCiPiT, by connecting at national level the top clinical trials units, PedCRIN, by developing tools specific for paediatric neonatal trials and providing operational support to paediatric pilot studies, and C4C, through the optimization of the delivery of paediatric clinical trials, are strengthening the efforts to reduce the lack of medicinal products tailored for children. In this scenario, where the collaboration and the exchange of information and knowledge are fundamental, TEDDY can represent a valid partner to face the challenges of the paediatric research. It can offer its experience in this context and consolidate its important role in the European paediatric research community framework, cooperating with the others to identify the most appropriate common rules that reflect the specificity of the patient population.

Related Posts

February 28th, 2018|